Literature DB >> 17044012

Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.

Caroline Godfrey1, Diana Escolar, Martin Brockington, Emma M Clement, Rachael Mein, Cecilia Jimenez-Mallebrera, Silvia Torelli, Lucy Feng, Susan C Brown, Caroline A Sewry, Mary Rutherford, Yehuda Shapira, Stephen Abbs, Francesco Muntoni.   

Abstract

OBJECTIVE: Defects in glycosylation of alpha-dystroglycan are associated with several forms of muscular dystrophy, often characterized by congenital onset and severe structural brain involvement, collectively known as dystroglycanopathies. Six causative genes have been identified in these disorders including fukutin. Mutations in fukutin cause Fukuyama congenital muscular dystrophy. This is the second most common form of muscular dystrophy in Japan and is invariably associated with mental retardation and structural brain defects. The aim of this study was to determine the genetic defect in two white families with a dystroglycanopathy.
METHODS: The six genes responsible for dystroglycanopathies were studied in three children with a severe reduction of alpha-dystroglycan in skeletal muscle.
RESULTS: We identified pathogenic fukutin mutations in these two families. Affected children had normal intelligence and brain structure and shared a limb girdle muscular dystrophy (LGMD) phenotype, had marked elevation of serum creatine kinase, and were all ambulant with remarkable steroid responsiveness.
INTERPRETATION: Our data suggest that fukutin mutations occur outside Japan and can be associated with much milder phenotypes than Fukuyama congenital muscular dystrophy. These findings significantly expand the spectrum of phenotypes associated with fukutin mutations to include this novel form of limb girdle muscular dystrophy that we propose to name LGMD2L.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044012     DOI: 10.1002/ana.21006

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration.

Authors:  Masaji Tachikawa; Motoi Kanagawa; Chih-Chieh Yu; Kazuhiro Kobayashi; Tatsushi Toda
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.

Authors:  Cristina Dias; Murat Sincan; Praveen F Cherukuri; Rosemarie Rupps; Yan Huang; Hannah Briemberg; Kathryn Selby; James C Mullikin; Thomas C Markello; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

Review 3.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 4.  [Standard treatment for myositis and muscular dystrophies].

Authors:  J Schmidt; M Vorgerd
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

5.  Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy.

Authors:  Mattia Quattrocelli; Isabella M Salamone; Patrick G Page; James L Warner; Alexis R Demonbreun; Elizabeth M McNally
Journal:  Am J Pathol       Date:  2017-08-18       Impact factor: 4.307

6.  Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming.

Authors:  Mattia Quattrocelli; Aaron S Zelikovich; Zhen Jiang; Clara Bien Peek; Alexis R Demonbreun; Nancy L Kuntz; Grant D Barish; Saptarsi M Haldar; Joseph Bass; Elizabeth M McNally
Journal:  JCI Insight       Date:  2019-12-19

Review 7.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.

Authors:  Babken Asatryan; Argelia Medeiros-Domingo
Journal:  J Mol Med (Berl)       Date:  2018-08-20       Impact factor: 4.599

8.  Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I.

Authors:  Marta Margeta; Anne M Connolly; Thomas L Winder; Alan Pestronk; Steven A Moore
Journal:  Muscle Nerve       Date:  2009-11       Impact factor: 3.217

9.  Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families.

Authors:  Wendy Chang; Thomas L Winder; Charles A LeDuc; Lynn L Simpson; William S Millar; Jeffrey Dungan; Norman Ginsberg; Stacey Plaga; Steven A Moore; Wendy K Chung
Journal:  Prenat Diagn       Date:  2009-06       Impact factor: 3.050

10.  Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.

Authors:  Rebecca L Puckett; Steven A Moore; Thomas L Winder; Tobias Willer; Stephen G Romansky; Kelly King Covault; Kevin P Campbell; Jose E Abdenur
Journal:  Neuromuscul Disord       Date:  2009-04-01       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.